Citadel Advisors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Citadel Advisors’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-30,100	Closed	-$1.03M	–	9281
2014 Q4	$1.03M	Sell	30,100 -6,500	-18%	-$212K	﹤0.01%	3728
2014 Q3	$1.09M	Buy	36,600 +12,700	+53%	+$269K	﹤0.01%	3605
2014 Q2	$479K	Sell	23,900 -2,400	-9%	-$55K	﹤0.01%	4456
2014 Q1	$715K	Sell	26,300 -16,800	-39%	-$446K	﹤0.01%	3857
2013 Q4	$894K	Buy	43,100 +16,300	+61%	+$307K	﹤0.01%	3324
2013 Q3	$489K	Buy	26,800 +6,500	+32%	+$117K	﹤0.01%	3842
2013 Q2	$338K	Buy	+20,300	New	+$324K	﹤0.01%	4190

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors's AUXL Position: Q3 2014 in Review

Citadel Advisors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2014, closing a stake of 4,697 shares — an estimated $99.6K sold.

Citadel Advisors first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $27.3M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2014.

Citadel Advisors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Citadel Advisors sold 4,697 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2014, an estimated $99.6K.
Citadel Advisors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
Citadel Advisors's AUXILIUM PHARAMCEUTICALS INC position peaked at $27.3M in Q2 2013.
150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2014.

Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.